Document is current
Any future updates will be listed below
-
Authors
Xie, Xinyi
Song, Qingxiang
Dai, Chengxiang
Cui, Shishuang
Tang, Ran
Li, Suke
Chang, Jing
Li, Ping
Wang, Jintao
Li, Jianping
Gao, Chao
Chen, Hongzhuan
Chen, Shengdi
Ren, Rujing
Gao, Xiaoling
Wang, Gang https://orcid.org/0000-0001-6500-5863
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04388982 at ClinicalTrials.govnct04388982 at ClinicalTrials.govDocuments that mention this clinical trial
Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer’s disease: a phase I/II clinical trial
https://doi.org/10.1136/gpsych-2023-101143
Documents that mention this clinical trial
Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer’s disease: a phase I/II clinical trial
https://doi.org/10.1136/gpsych-2023-101143
-
Funding
Funding for this research was provided by:
Grant from Shanghai Science and Technology Committee (121XD1422200)
National Natural Science Foundation of China (81903582)
National Natural Science Foundation of China (81973272)
National Natural Science Foundation of China (92068111)
Cellular Biomedicine Group, Inc. (N/A)
Ministry of Science and Technology of the People's Republic of China (2021ZD0201804)
Natural Science Foundation of Shanghai Municipality (219ZR1431500)
- License Information
